Hadas Shiran
Cardiovascular Disease (Cardiology) · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 4 carriers
- Offices
- 7
Offices
7 locations · Stanford Health Care · Sutter Bay Medical Foundation
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
10 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Hadas Shiran’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A103909 · Current
Licensed to practise in California · since 2008 · expires 2027-08-31 · Dartmouth Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$29,671
Medicare paid this office $29,671 for 429 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 163 | $9,661 | $59 |
| Critical care, first 30-74 minutes | 12 | $4,324 | $180 |
| Short return visit (20+ min) | 57 | $2,619 | $45 |
| Return visit (30+ min) | 30 | $2,544 | $85 |
| New patient visit (45+ min) | 15 | $2,406 | $160 |
See all 11 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 163 | $9,661 | $59 |
| Critical care, first 30-74 minutes | 12 | $4,324 | $180 |
| Short return visit (20+ min) | 57 | $2,619 | $45 |
| Return visit (30+ min) | 30 | $2,544 | $85 |
| New patient visit (45+ min) | 15 | $2,406 | $160 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $1,991 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,349 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 110 | $928 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 31 | $470 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 31 | $314 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 11 | $58 | $5 |
Who their Medicare patients are
429 Original Medicare patients in 2024. Average age 74 · Under 65 11% · 85 and older 17% · Women 51% · Also on Medicaid 73% · Health risk score 2.24. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Diabetes 52% · Coronary heart disease 47% · Heart failure 43% · Atrial fibrillation 41% · Chronic kidney disease 40% · Depression 22% · Stroke 21% · COPD 19% · Dementia 18% · Cancer 14%.
The office billed $329,959, Medicare allowed $40,364 and paid $29,671; for 582 services of 24 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 429 | 582 | 74 | 2.24 | $329,959 | $29,671 |
| 2023 | 504 | 732 | 72 | 2.41 | $347,154 | $32,676 |
| 2022 | 526 | 742 | 72 | 2.12 | $362,313 | $36,009 |
| 2021 | 629 | 906 | 73 | 2.23 | $346,259 | $37,791 |
| 2020 | 571 | 787 | 72 | 2.30 | $263,558 | $25,803 |
| 2019 | 754 | 1,143 | 70 | 2.22 | $465,959 | $44,254 |
| 2016 | 14 | 14 | 70 | 0.69 | $4,315 | $943 |
| 2015 | 125 | 185 | 73 | 1.85 | $48,390 | $9,834 |
| 2014 | 253 | 413 | 72 | 2.02 | $96,316 | $19,411 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 187 | $11,065 | $59 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 40 | $4,962 | $124 |
| Short return visit (20+ min) | 73 | $4,176 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $3,703 | $77 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 161 | $1,414 | $7 |
| Return visit (30+ min) | 13 | $1,038 | $74 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 30 | $475 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 30 | $323 | $11 |
| Ultrasound of heart, follow-up | 11 | $298 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 16 | $236 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 16 | $155 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 11 | $67 | $6 |
2022: 14 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 188 | $11,589 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $4,250 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $3,956 | $113 |
| Short return visit (20+ min) | 45 | $2,671 | $56 |
| Return visit (30+ min) | 25 | $2,213 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,809 | $79 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 153 | $1,232 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 37 | $644 | $17 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $500 | $36 |
| Telephone medical discussion with physician, 5-10 minutes | 21 | $478 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 37 | $432 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 19 | $241 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 27 | $168 | $6 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 19 | $162 | $9 |
2021: 14 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 180 | $11,460 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 34 | $5,386 | $150 |
| Return visit (30+ min) | 39 | $4,055 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $3,054 | $117 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 278 | $2,421 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $2,257 | $78 |
| Telephone medical discussion with physician, 5-10 minutes | 38 | $1,333 | $31 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 41 | $612 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 41 | $415 | $10 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $403 | $37 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 18 | $285 | $16 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 11 | $280 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 18 | $192 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 32 | $178 | $6 |
2020: 11 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 172 | $11,005 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 263 | $2,432 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,824 | $107 |
| Telephone medical discussion with physician, 11-20 minutes | 41 | $1,760 | $42 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,592 | $145 |
| Telephone medical discussion with physician, 5-10 minutes | 31 | $618 | $20 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 19 | $472 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 29 | $439 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 29 | $295 | $10 |
| Short return visit (20+ min) | 14 | $272 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 31 | $141 | $4 |
2019: 13 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 154 | $10,427 | $66 |
| Critical care, first 30-74 minutes | 19 | $7,260 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 39 | $5,872 | $95 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,479 | $120 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 370 | $3,400 | $8 |
| Return visit (30+ min) | 37 | $3,014 | $70 |
| Short return visit (20+ min) | 57 | $2,564 | $42 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 51 | $981 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 51 | $661 | $13 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 19 | $492 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 72 | $434 | $6 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 23 | $430 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 23 | $289 | $13 |
2015: 4 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 85 | $4,779 | $56 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 18 | $1,159 | $64 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 18 | $360 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 18 | $235 | $13 |
2014: 7 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 172 | $9,806 | $56 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 45 | $2,818 | $63 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $1,126 | $94 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 44 | $854 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 44 | $560 | $13 |
| Ultrasound of heart blood flow, valves and chambers | 14 | $232 | $17 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 25 | $75 | $3 |
Medicaid work
$9,623 in 2024
Medicaid paid $9,623 for 1,495 billed services this clinician did in 2024, up to 71 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 396 | $6,208 |
| Short return visit (20+ min) | 85 | $1,132 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 287 | $1,124 |
| CARDIOVASCULAR STRESS TEST | 101 | $657 |
| CARDIOVASCULAR STRESS TEST | 101 | $406 |
| Return visit (30+ min) | 19 | $98 |
| Pain severity quantified; no pain present (COA) (ONC) | 26 | $0 |
| Medication list documented in medical record (COA) | 138 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 136 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 53 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 12 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 141 | $0 |
| 2024 | 1,495 | 12 | 71 | $9,623 |
| 2023 | 1,657 | 8 | 118 | $12,535 |
| 2022 | 1,318 | 7 | 63 | $13,378 |
| 2021 | 1,928 | 5 | 84 | $17,922 |
| 2020 | 1,285 | 6 | 81 | $12,209 |
| 2019 | 1,616 | 5 | 86 | $11,104 |
| 2018 | 1,290 | 5 | 87 | $9,363 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 629 | $8,544 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 564 | $1,898 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 39 | $685 |
| CARDIOVASCULAR STRESS TEST | 145 | $651 |
| CARDIOVASCULAR STRESS TEST | 145 | $418 |
| Short return visit (20+ min) | 93 | $339 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 15 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 27 | $0 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 452 | $7,893 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 474 | $2,234 |
| Return visit (30+ min) | 82 | $1,197 |
| CARDIOVASCULAR STRESS TEST | 124 | $1,028 |
| CARDIOVASCULAR STRESS TEST | 124 | $653 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 12 | $188 |
| Short return visit (20+ min) | 50 | $184 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 545 | $10,924 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 986 | $3,960 |
| Return visit (30+ min) | 203 | $2,091 |
| CARDIOVASCULAR STRESS TEST | 97 | $580 |
| CARDIOVASCULAR STRESS TEST | 97 | $367 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 409 | $8,093 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 745 | $3,198 |
| CARDIOVASCULAR STRESS TEST | 49 | $397 |
| CARDIOVASCULAR STRESS TEST | 49 | $255 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 16 | $189 |
| Short return visit (20+ min) | 17 | $77 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 382 | $6,824 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 942 | $3,244 |
| CARDIOVASCULAR STRESS TEST | 133 | $607 |
| CARDIOVASCULAR STRESS TEST | 133 | $387 |
| Short return visit (20+ min) | 26 | $41 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 259 | $5,094 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 789 | $3,202 |
| CARDIOVASCULAR STRESS TEST | 109 | $556 |
| CARDIOVASCULAR STRESS TEST | 109 | $356 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 24 | $154 |
Drugs they prescribed that Part D paid
$59,717
Pharmacies billed $59,717 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 346) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
271 generic and 75 brand-name prescriptions · $59,717 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 28 | $25,519 | $911 |
| Xarelto | 12 | $8,878 | $740 |
| Praluent | 11 | $4,846 | $441 |
| Metoprolol | 58 | $667 | $12 |
| Isosorbide Mononitrate Er | 33 | $355 | $11 |
See all 12 drugs
| Eliquis | 28 | $25,519 | $911 |
| Xarelto | 12 | $8,878 | $740 |
| Praluent | 11 | $4,846 | $441 |
| Metoprolol | 58 | $667 | $12 |
| Isosorbide Mononitrate Er | 33 | $355 | $11 |
| Clopidogrel | 24 | $208 | $9 |
| Ranolazine Er | 11 | $193 | $18 |
| Atorvastatin | 26 | $174 | $7 |
| Metoprolol | 35 | $123 | $4 |
| Nitroglycerin | 13 | $93 | $7 |
| Carvedilol | 20 | $63 | $3 |
| Lisinopril | 11 | $18 | $2 |
Year by year
| 2024 | 346 | 102 | 0% (0) | 22% | $59,717 |
| 2023 | 265 | 78 | 0% (0) | 25% | $42,151 |
| 2022 | 261 | 63 | 0% (0) | 28% | $41,189 |
| 2021 | 262 | 60 | 0% (0) | 38% | $48,315 |
| 2020 | 196 | 57 | 0% (0) | 41% | $35,121 |
| 2019 | 233 | 60 | 0% (0) | 39% | $34,498 |
| 2018 | 255 | 71 | 0% (0) | 24% | $23,629 |
| 2017 | 319 | 73 | 0% (0) | 27% | $27,345 |
| 2016 | 353 | 79 | None | 18% | $20,321 |
| 2015 | 260 | 48 | 0% (0) | 17% | $15,824 |
| 2014 | 201 | 44 | None | 17% | $8,738 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Xarelto | 19 | $13,271 | $698 |
| Brilinta | 15 | $10,670 | $711 |
| Eliquis | 11 | $6,684 | $608 |
| Ranolazine Er | 15 | $1,223 | $82 |
| Isosorbide Mononitrate Er | 28 | $1,019 | $36 |
| Metoprolol | 32 | $551 | $17 |
| Atorvastatin | 23 | $492 | $21 |
| Carvedilol | 22 | $483 | $22 |
| Clopidogrel | 15 | $256 | $17 |
| Metoprolol | 19 | $198 | $10 |
| Losartan | 11 | $197 | $18 |
| Nitroglycerin | 17 | $182 | $11 |
2022: 10 drugs
| Xarelto | 31 | $14,924 | $481 |
| Eliquis | 19 | $12,813 | $674 |
| Brilinta | 14 | $7,581 | $542 |
| Ranolazine Er | 19 | $1,765 | $93 |
| Isosorbide Mononitrate Er | 32 | $927 | $29 |
| Metoprolol | 21 | $556 | $26 |
| Carvedilol | 31 | $415 | $13 |
| Atorvastatin | 17 | $193 | $11 |
| Clopidogrel | 12 | $123 | $10 |
| Metoprolol | 12 | $96 | $8 |
2021: 8 drugs
| Eliquis | 41 | $23,867 | $582 |
| Xarelto | 33 | $14,558 | $441 |
| Isosorbide Mononitrate Er | 31 | $703 | $23 |
| Metoprolol | 21 | $414 | $20 |
| Carvedilol | 28 | $293 | $10 |
| Atorvastatin | 11 | $190 | $17 |
| Clopidogrel | 13 | $150 | $12 |
| Metoprolol | 23 | $100 | $4 |
2020: 6 drugs
| Eliquis | 48 | $25,607 | $533 |
| Xarelto | 12 | $5,482 | $457 |
| Metoprolol | 13 | $278 | $21 |
| Isosorbide Mononitrate Er | 14 | $255 | $18 |
| Atorvastatin | 15 | $181 | $12 |
| Clopidogrel | 17 | $139 | $8 |
2019: 9 drugs
| Eliquis | 45 | $19,591 | $435 |
| Xarelto | 13 | $5,792 | $446 |
| Ranexa | 14 | $5,277 | $377 |
| Isosorbide Mononitrate Er | 17 | $592 | $35 |
| Metoprolol | 16 | $557 | $35 |
| Nitroglycerin | 22 | $313 | $14 |
| Clopidogrel | 22 | $206 | $9 |
| Atorvastatin | 16 | $193 | $12 |
| Lisinopril | 15 | $47 | $3 |
2018: 13 drugs
| Xarelto | 23 | $9,439 | $410 |
| Eliquis | 21 | $9,352 | $445 |
| Isosorbide Mononitrate Er | 34 | $928 | $27 |
| Metoprolol | 11 | $385 | $35 |
| Atorvastatin | 12 | $308 | $26 |
| Hydralazine | 14 | $185 | $13 |
| Nitroglycerin | 11 | $182 | $17 |
| Clopidogrel | 16 | $160 | $10 |
| Carvedilol | 14 | $123 | $9 |
| Metoprolol | 20 | $112 | $6 |
| Hydrochlorothiazide | 18 | $89 | $5 |
| Lisinopril | 12 | $57 | $5 |
| Clonidine | 11 | $40 | $4 |
2017: 10 drugs
| Eliquis | 25 | $12,147 | $486 |
| Xarelto | 35 | $11,031 | $315 |
| Isosorbide Mononitrate Er | 47 | $991 | $21 |
| Atorvastatin | 28 | $437 | $16 |
| Metoprolol | 20 | $405 | $20 |
| Nitroglycerin | 12 | $222 | $19 |
| Metoprolol | 25 | $135 | $5 |
| Amlodipine Besylate | 14 | $112 | $8 |
| Hydrochlorothiazide | 22 | $105 | $5 |
| Clopidogrel | 18 | $89 | $5 |
2016: 12 drugs
| Xarelto | 24 | $7,031 | $293 |
| Eliquis | 18 | $6,741 | $374 |
| Metoprolol | 25 | $1,129 | $45 |
| Isosorbide Mononitrate Er | 46 | $1,058 | $23 |
| Atorvastatin | 23 | $681 | $30 |
| Metoprolol | 38 | $290 | $8 |
| Hydrochlorothiazide | 20 | $241 | $12 |
| Clopidogrel | 18 | $216 | $12 |
| Losartan | 24 | $141 | $6 |
| Amlodipine Besylate | 17 | $111 | $7 |
| Clonidine | 12 | $107 | $9 |
| Lisinopril | 12 | $62 | $5 |
2015: 7 drugs
| Eliquis | 14 | $4,543 | $324 |
| Metoprolol | 22 | $979 | $44 |
| Isosorbide Mononitrate Er | 28 | $431 | $15 |
| Hydrochlorothiazide | 34 | $354 | $10 |
| Losartan | 19 | $206 | $11 |
| Metoprolol | 25 | $89 | $4 |
| Clonidine | 12 | $80 | $7 |
2014: 6 drugs
| Metoprolol | 19 | $1,034 | $54 |
| Isosorbide Mononitrate Er | 24 | $367 | $15 |
| Losartan | 12 | $333 | $28 |
| Carvedilol | 14 | $267 | $19 |
| Hydrochlorothiazide | 30 | $142 | $5 |
| Metoprolol | 17 | $58 | $3 |
Money from drug and device companies
$58 in 2025
A payment is not proof that care is biased.
| Novartis Pharmaceuticals | Leqvio | $30 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $29 | 1 payment
|
See all 2 published payments
| E.R. Squibb & Sons L.L.C. | Meals · 2025-12-02 | Eliquis | $29 |
| Novartis Pharmaceuticals | Meals · 2025-07-31 | Leqvio | $30 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1427170539
- Licence
- CA A103909California A103909: Current · expires 2027-08-31
- Group
- Stanford Health Care · Sutter Bay Medical Foundation
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-04-06
- NPI last updated
- 2024-10-10
- NPI record certified
- 2024-10-10
This is when the NPI record was last certified, not a medical board exam.